Consumer

The virtual care company plans to add devices that can transmit metrics like blood pressure or glucose levels to MDLIVE's patient portal later this year.

The app also helped children meet therapeutic goals. However, it didn't make a significant difference in overall anxiety or functional impairments.

Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.

Berlin startup targets irritable bowel syndrome and other gastrointestinal problems with a digital therapy program.

The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.

The male and female hormone tests are the first product in the company's Kind at Home consumer products division.

The company is now offering a topical Finasteride and Minoxidil spray as well as oral spironolactone through its virtual care platform. 

This week's top stories include a class action complaint accusing QRS of failing to secure, monitor and maintain patient data after a breach that affected nearly 320,000 people, and Headspace Health's aim to improve its ability to personalize users' experiences with its Sayana acquisition.

Also, Tech accelerator calls for gut health startups in the EMEA region